NCT00547495

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Tadalafil Administered "On Demand" to Patients With Erectile Dysfunction

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 343 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Male
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

Study to determine how safe and effective tadalafil is for Japanese men taking it when they need to get and keep an erection.

Conditions

• Impotence

Interventions

Type	Name	Description
DRUG	tadalafil	5 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks
DRUG	placebo	placebo tablet taken by mouth, as needed, no more than 1 dose per day, for 12 weeks
DRUG	tadalafil	10 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks
DRUG	tadalafil	20 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

Timeline

• Start date: 2004-03-01
• Completion: 2004-11-01
• First posted: 2007-10-22
• Last updated: 2007-10-22

Locations

1 site across 1 country: Japan